Pete Meyers
Direttore/Membro del Consiglio presso IMMUTEP LIMITED
Patrimonio netto: 914 277 $ in data 30/04/2024
Posizioni attive di Pete Meyers
Società | Posizione | Inizio | Fine |
---|---|---|---|
IMMUTEP LIMITED | Direttore/Membro del Consiglio | 12/02/2014 | - |
Independent Dir/Board Member | 12/02/2014 | - | |
Thomas M Brennan Memorial Foundation, Inc. | Presidente | 01/09/2001 | - |
Presidente | 01/09/2001 | - | |
East End Hospice, Inc. | Direttore/Membro del Consiglio | - | - |
Slayback Pharma LLC
Slayback Pharma LLC Pharmaceuticals: GenericHealth Technology Slayback Pharma LLC is a specialty pharmaceutical company focused on developing, manufacturing and sourcing of complex generic pharmaceutical products, with a specific emphasis on complex injectables and other non-solid oral products. The company is headquartered in Princeton Junction, NJ. | Direttore Finanziario/CFO | - | - |
Hospice, Inc. (Iowa)
Hospice, Inc. (Iowa) Medical/Nursing ServicesHealth Services Hospice, Inc. is a private company based in Ottumwa, IA and has subsidiaries in United States. The company provides hospice care. | Direttore/Membro del Consiglio | - | - |
Storia della carriera di Pete Meyers
Precedenti posizioni note di Pete Meyers
Società | Posizione | Inizio | Fine |
---|---|---|---|
EAGLE PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 15/05/2017 | 29/10/2020 |
MOTIF BIO PLC | Comptroller/Controller/Auditor | 01/05/2016 | 17/01/2017 |
Direttore Finanziario/CFO | 01/05/2016 | 17/01/2017 | |
Motif BioSciences, Inc.
Motif BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Motif BioSciences, Inc. develops antibiotics designed to be effective against serious and life-threatening infections. The company was founded on June 8, 2004 and is headquartered in New York, NY. | Direttore Finanziario/CFO | 01/05/2016 | 01/01/2017 |
TETRALOGIC PHARMACEUTICALS CORPORATION | Direttore Finanziario/CFO | 19/08/2013 | 01/03/2016 |
Treasurer | 01/09/2013 | 01/03/2016 | |
░░░░░░░░ ░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░ ░░░░ ░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formazione di Pete Meyers
Boston College | Undergraduate Degree |
Columbia Business School | Masters Business Admin |
Statistiche
Distribuzione geografica
Stati Uniti | 13 |
Australia | 2 |
Posizioni
Director of Finance/CFO | 5 |
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
Settori
Health Technology | 7 |
Consumer Services | 3 |
Finance | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
TETRALOGIC PHARMACEUTICALS CORPORATION | Health Technology |
IMMUTEP LIMITED | Health Technology |
EAGLE PHARMACEUTICALS, INC. | Health Technology |
Aziende private | 8 |
---|---|
Deutsche Bank Securities, Inc.
Deutsche Bank Securities, Inc. Investment Banks/BrokersFinance Deutsche Bank Securities, Inc. (DBSI) is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 1971 and is a wholly-owned investment banking and brokerage arm of DB U.S. Financial Markets Holding Corp., ultimately held by Deutsche Bank AG (NYSE: DB, FRA: DBK) in Germany. DBSI provides securities brokerage and investment advisory services to domestic and international private clients and institutions. They are also a primary dealer in US government securities as designated by the Federal Reserve. | Finance |
Dillon, Read & Co., Inc. | Finance |
Thomas M Brennan Memorial Foundation, Inc. | |
Motif Bio Plc
Motif Bio Plc Pharmaceuticals: MajorHealth Technology Motif Bio Plc is a clinical stage biopharmaceutical company, which engages in the development and commercialization of pharmaceutical formulations. The company focuses on developing novel antibiotics designed to be effective against serious and life-threatening infections caused by multi-drug resistant bacteria. It offers Iclaprim, a novel diaminopyrimidine antibiotic that inhibits an essential bacterial enzyme called dihydrofolate reductase. The company was founded by Jonathan E. Gold on November 20, 2014 and is headquartered in Princeton, NJ. | Health Technology |
Motif BioSciences, Inc.
Motif BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Motif BioSciences, Inc. develops antibiotics designed to be effective against serious and life-threatening infections. The company was founded on June 8, 2004 and is headquartered in New York, NY. | Health Technology |
East End Hospice, Inc. | |
Slayback Pharma LLC
Slayback Pharma LLC Pharmaceuticals: GenericHealth Technology Slayback Pharma LLC is a specialty pharmaceutical company focused on developing, manufacturing and sourcing of complex generic pharmaceutical products, with a specific emphasis on complex injectables and other non-solid oral products. The company is headquartered in Princeton Junction, NJ. | Health Technology |
Hospice, Inc. (Iowa)
Hospice, Inc. (Iowa) Medical/Nursing ServicesHealth Services Hospice, Inc. is a private company based in Ottumwa, IA and has subsidiaries in United States. The company provides hospice care. | Health Services |
- Borsa valori
- Insiders
- Pete Meyers
- Esperienza